BCL3 and colorectal cancer: Expression of BCL3 and β-catenin was inversely correlated in colorectal cancer cell lines and targeted knockdown of β-catenin promoted BCL3 expression [13], while stimulation of the pathway by exogenous Wnt3a administration also led to an increase in BCL3 expression in the same cell lines [56].